APO Research

APO RESEARCH · REPORT

Fulvestrant

Selected research

Market Outlook & Growth Opportunities

Global Fulvestrant Market Outlook and Growth Opportunities 2026

Market perspective

The global Fulvestrant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fulvestrant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fulvestrant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fulvestrant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fulvestrant market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fulvestrant market include Teva, Novartis, AstraZeneca, Natco, Intas Pharmaceuticals, Chemo, Amneal Pharms and Accure Labs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fulvestrant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fulvestrant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fulvestrant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fulvestrant market size, projected growth trends, production technologies, key applications, and end-use industries.

Fulvestrant Segment by Company

Teva

Novartis

AstraZeneca

Natco

Intas Pharmaceuticals

Chemo

Amneal Pharms

Accure Labs

Fulvestrant Segment by Type

1 Injection/Box

2 Injection/Box

Fulvestrant Segment by Application

Drug Center

Hospital

Clinic

Others

Fulvestrant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fulvestrant status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fulvestrant market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fulvestrant significant trends, drivers, influence factors in global and regions.

6. To analyze Fulvestrant competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fulvestrant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fulvestrant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fulvestrant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fulvestrant market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fulvestrant industry.

Chapter 3: Detailed analysis of Fulvestrant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fulvestrant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fulvestrant in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fulvestrant Industry Trends Table 2. Fulvestrant Industry Drivers Table 3. Fulvestrant Industry Opportunities and Challenges Table 4. Fulvestrant Industry Restraints Table 5. Global Fulvestrant Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fulvestrant Revenue Share by Company (2021-2026) Table 7. Global Fulvestrant Sales Volume by Company (k units) & (2021-2026) Table 8. Global Fulvestrant Sales Volume Share by Company (2021-2026) Table 9. Global Fulvestrant Average Price (US$/unit) of Company (2021-2026) Table 10. Global Fulvestrant Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fulvestrant Key Company Manufacturing Base & Headquarters Table 12. Global Fulvestrant Company, Product Type & Application Table 13. Global Fulvestrant Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fulvestrant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1 Injection/Box Table 18. Significant Companies of 2 Injection/Box Table 19. Global Fulvestrant Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Fulvestrant Sales Volume by Type (2021-2026) & (k units) Table 21. Global Fulvestrant Sales Volume by Type (2027-2032) & (k units) Table 22. Global Fulvestrant Sales Volume Share by Type (2021-2026) Table 23. Global Fulvestrant Sales Volume Share by Type (2027-2032) Table 24. Global Fulvestrant Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fulvestrant Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Fulvestrant Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Fulvestrant Sales Value Share by Type (2021-2026) Table 28. Global Fulvestrant Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Drug Center Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Fulvestrant Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Fulvestrant Sales Volume by Application (2021-2026) & (k units) Table 35. Global Fulvestrant Sales Volume by Application (2027-2032) & (k units) Table 36. Global Fulvestrant Sales Volume Share by Application (2021-2026) Table 37. Global Fulvestrant Sales Volume Share by Application (2027-2032) Table 38. Global Fulvestrant Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Fulvestrant Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Fulvestrant Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Fulvestrant Sales Value Share by Application (2021-2026) Table 42. Global Fulvestrant Sales Value Share by Application (2027-2032) Table 43. Global Fulvestrant Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Fulvestrant Sales by Region (2021-2026) & (k units) Table 45. Global Fulvestrant Sales Market Share by Region (2021-2026) Table 46. Global Fulvestrant Sales by Region (2027-2032) & (k units) Table 47. Global Fulvestrant Sales Market Share by Region (2027-2032) Table 48. Global Fulvestrant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Fulvestrant Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Fulvestrant Sales Value Share by Region (2021-2026) Table 51. Global Fulvestrant Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Fulvestrant Sales Value Share by Region (2027-2032) Table 53. Global Fulvestrant Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Fulvestrant Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Fulvestrant Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Fulvestrant Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Fulvestrant Sales by Country (2021-2026) & (k units) Table 58. Global Fulvestrant Sales Market Share by Country (2021-2026) Table 59. Global Fulvestrant Sales by Country (2027-2032) & (k units) Table 60. Global Fulvestrant Sales Market Share by Country (2027-2032) Table 61. Global Fulvestrant Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Fulvestrant Sales Value Market Share by Country (2021-2026) Table 63. Global Fulvestrant Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Fulvestrant Sales Value Market Share by Country (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Teva Fulvestrant Product Portfolio Table 69. Teva Recent Development Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Novartis Fulvestrant Product Portfolio Table 74. Novartis Recent Development Table 75. AstraZeneca Company Information Table 76. AstraZeneca Business Overview Table 77. AstraZeneca Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. AstraZeneca Fulvestrant Product Portfolio Table 79. AstraZeneca Recent Development Table 80. Natco Company Information Table 81. Natco Business Overview Table 82. Natco Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Natco Fulvestrant Product Portfolio Table 84. Natco Recent Development Table 85. Intas Pharmaceuticals Company Information Table 86. Intas Pharmaceuticals Business Overview Table 87. Intas Pharmaceuticals Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Intas Pharmaceuticals Fulvestrant Product Portfolio Table 89. Intas Pharmaceuticals Recent Development Table 90. Chemo Company Information Table 91. Chemo Business Overview Table 92. Chemo Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Chemo Fulvestrant Product Portfolio Table 94. Chemo Recent Development Table 95. Amneal Pharms Company Information Table 96. Amneal Pharms Business Overview Table 97. Amneal Pharms Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Amneal Pharms Fulvestrant Product Portfolio Table 99. Amneal Pharms Recent Development Table 100. Accure Labs Company Information Table 101. Accure Labs Business Overview Table 102. Accure Labs Fulvestrant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Accure Labs Fulvestrant Product Portfolio Table 104. Accure Labs Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Fulvestrant Distributors List Table 108. Fulvestrant Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Fulvestrant Product Image Figure 2. Global Fulvestrant Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fulvestrant Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fulvestrant Sales (2021-2032) & (k units) Figure 5. Global Fulvestrant Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Fulvestrant Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1 Injection/Box Image Figure 10. 2 Injection/Box Image Figure 11. Global Fulvestrant Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Fulvestrant Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Fulvestrant Sales Volume Share by Type (2021-2032) Figure 14. Global Fulvestrant Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Fulvestrant Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Fulvestrant Sales Value Share by Type (2021-2032) Figure 17. Drug Center Image Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Fulvestrant Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Fulvestrant Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Fulvestrant Sales Volume Share by Application (2021-2032) Figure 24. Global Fulvestrant Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Fulvestrant Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Fulvestrant Sales Value Share by Application (2021-2032) Figure 27. Global Fulvestrant Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Fulvestrant Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Fulvestrant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Fulvestrant Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Fulvestrant Sales Value (2021-2032) & (US$ Million) Figure 32. North America Fulvestrant Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Fulvestrant Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Fulvestrant Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Fulvestrant Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Fulvestrant Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Fulvestrant Sales Value (2021-2032) & (US$ Million) Figure 38. South America Fulvestrant Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Fulvestrant Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Fulvestrant Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Fulvestrant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Fulvestrant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Fulvestrant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Fulvestrant Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Fulvestrant Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 1 Injection/Box
  • 2 Injection/Box
Applications
  • Drug Center
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Novartis
  • AstraZeneca
  • Natco
  • Intas Pharmaceuticals
  • Chemo
  • Amneal Pharms
  • Accure Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fulvestrant Sales Value (2021-2032)
  4. 1.2.2 Global Fulvestrant Sales Volume (2021-2032)
  5. 1.2.3 Global Fulvestrant Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fulvestrant Market Dynamics
  1. 2.1 Fulvestrant Industry Trends
  2. 2.2 Fulvestrant Industry Drivers
  3. 2.3 Fulvestrant Industry Opportunities and Challenges
  4. 2.4 Fulvestrant Industry Restraints
3 Fulvestrant Market by Company
  1. 3.1 Global Fulvestrant Company Revenue Ranking in 2025
  2. 3.2 Global Fulvestrant Revenue by Company (2021-2026)
  3. 3.3 Global Fulvestrant Sales Volume by Company (2021-2026)
  4. 3.4 Global Fulvestrant Average Price by Company (2021-2026)
  5. 3.5 Global Fulvestrant Company Ranking (2024-2026)
  6. 3.6 Global Fulvestrant Company Manufacturing Base and Headquarters
  7. 3.7 Global Fulvestrant Company Product Type and Application
  8. 3.8 Global Fulvestrant Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fulvestrant Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fulvestrant Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fulvestrant Market by Type
  1. 4.1 Fulvestrant Type Introduction
  2. 4.1.1 1 Injection/Box
  3. 4.1.2 2 Injection/Box
  4. 4.2 Global Fulvestrant Sales Volume by Type
  5. 4.2.1 Global Fulvestrant Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fulvestrant Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Fulvestrant Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Fulvestrant Sales Value by Type
  9. 4.3.1 Global Fulvestrant Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fulvestrant Sales Value by Type (2021-2032)
  11. 4.3.3 Global Fulvestrant Sales Value Share by Type (2021-2032)
5 Fulvestrant Market by Application
  1. 5.1 Fulvestrant Application Introduction
  2. 5.1.1 Drug Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Others
  6. 5.2 Global Fulvestrant Sales Volume by Application
  7. 5.2.1 Global Fulvestrant Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Fulvestrant Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Fulvestrant Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Fulvestrant Sales Value by Application
  11. 5.3.1 Global Fulvestrant Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Fulvestrant Sales Value by Application (2021-2032)
  13. 5.3.3 Global Fulvestrant Sales Value Share by Application (2021-2032)
6 Fulvestrant Regional Sales and Value Analysis
  1. 6.1 Global Fulvestrant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fulvestrant Sales by Region (2021-2032)
  3. 6.2.1 Global Fulvestrant Sales by Region: 2021-2026
  4. 6.2.2 Global Fulvestrant Sales by Region (2027-2032)
  5. 6.3 Global Fulvestrant Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fulvestrant Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fulvestrant Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fulvestrant Sales Value by Region (2027-2032)
  9. 6.5 Global Fulvestrant Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fulvestrant Sales Value (2021-2032)
  12. 6.6.2 North America Fulvestrant Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fulvestrant Sales Value (2021-2032)
  15. 6.7.2 Europe Fulvestrant Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fulvestrant Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fulvestrant Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fulvestrant Sales Value (2021-2032)
  21. 6.9.2 South America Fulvestrant Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fulvestrant Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fulvestrant Sales Value Share by Country, 2025 VS 2032
7 Fulvestrant Country-level Sales and Value Analysis
  1. 7.1 Global Fulvestrant Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fulvestrant Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fulvestrant Sales by Country (2021-2032)
  4. 7.3.1 Global Fulvestrant Sales by Country (2021-2026)
  5. 7.3.2 Global Fulvestrant Sales by Country (2027-2032)
  6. 7.4 Global Fulvestrant Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fulvestrant Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fulvestrant Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fulvestrant Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fulvestrant Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fulvestrant Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fulvestrant Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fulvestrant Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fulvestrant Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fulvestrant Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fulvestrant Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fulvestrant Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fulvestrant Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fulvestrant Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fulvestrant Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fulvestrant Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fulvestrant Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fulvestrant Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fulvestrant Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fulvestrant Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fulvestrant Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fulvestrant Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fulvestrant Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fulvestrant Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fulvestrant Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fulvestrant Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fulvestrant Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fulvestrant Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fulvestrant Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fulvestrant Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fulvestrant Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fulvestrant Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fulvestrant Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fulvestrant Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fulvestrant Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fulvestrant Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fulvestrant Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fulvestrant Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fulvestrant Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fulvestrant Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fulvestrant Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fulvestrant Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fulvestrant Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fulvestrant Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fulvestrant Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fulvestrant Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fulvestrant Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fulvestrant Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fulvestrant Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fulvestrant Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fulvestrant Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fulvestrant Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fulvestrant Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fulvestrant Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fulvestrant Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fulvestrant Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fulvestrant Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fulvestrant Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fulvestrant Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fulvestrant Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fulvestrant Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fulvestrant Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fulvestrant Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fulvestrant Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fulvestrant Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fulvestrant Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fulvestrant Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fulvestrant Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fulvestrant Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fulvestrant Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fulvestrant Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fulvestrant Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fulvestrant Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fulvestrant Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fulvestrant Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fulvestrant Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fulvestrant Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fulvestrant Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fulvestrant Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fulvestrant Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fulvestrant Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fulvestrant Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fulvestrant Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fulvestrant Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fulvestrant Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fulvestrant Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fulvestrant Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Fulvestrant Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Fulvestrant Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Fulvestrant Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Fulvestrant Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Fulvestrant Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Fulvestrant Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Natco
  20. 8.4.1 Natco Company Information
  21. 8.4.2 Natco Business Overview
  22. 8.4.3 Natco Fulvestrant Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Natco Fulvestrant Product Portfolio
  24. 8.4.5 Natco Recent Developments
  25. 8.5 Intas Pharmaceuticals
  26. 8.5.1 Intas Pharmaceuticals Company Information
  27. 8.5.2 Intas Pharmaceuticals Business Overview
  28. 8.5.3 Intas Pharmaceuticals Fulvestrant Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Intas Pharmaceuticals Fulvestrant Product Portfolio
  30. 8.5.5 Intas Pharmaceuticals Recent Developments
  31. 8.6 Chemo
  32. 8.6.1 Chemo Company Information
  33. 8.6.2 Chemo Business Overview
  34. 8.6.3 Chemo Fulvestrant Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chemo Fulvestrant Product Portfolio
  36. 8.6.5 Chemo Recent Developments
  37. 8.7 Amneal Pharms
  38. 8.7.1 Amneal Pharms Company Information
  39. 8.7.2 Amneal Pharms Business Overview
  40. 8.7.3 Amneal Pharms Fulvestrant Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Amneal Pharms Fulvestrant Product Portfolio
  42. 8.7.5 Amneal Pharms Recent Developments
  43. 8.8 Accure Labs
  44. 8.8.1 Accure Labs Company Information
  45. 8.8.2 Accure Labs Business Overview
  46. 8.8.3 Accure Labs Fulvestrant Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Accure Labs Fulvestrant Product Portfolio
  48. 8.8.5 Accure Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fulvestrant Value Chain Analysis
  2. 9.1.1 Fulvestrant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fulvestrant Sales Mode & Process
  6. 9.2 Fulvestrant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fulvestrant Distributors
  9. 9.2.3 Fulvestrant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research